ESCI期刊Translational and Clinical Pharmacology 2024/2025影响因子:1.161 (TRANSL CLIN PHARMACO) (2289-0882). (PHARMACOLOGY & P

显示全部楼层 · 发表于 2025-3-23 14:00:07

Submitted on: 05 February 1999. Revised on: 21 February 1999. Accepted on: 02 March 1999. Translational and Clinical Pharmacology

显示全部楼层 · 发表于 2025-3-23 20:42:41

Submitted on: 01 August 2016. Revised on: 09 August 2016. Accepted on: 18 August 2016. Translational and Clinical Pharmacology

显示全部楼层 · 发表于 2025-3-24 01:40:22

显示全部楼层 · 发表于 2025-3-24 02:39:51

Submitted on: 30 May 2008. Revised on: 30 June 2008. Accepted on: 28 July 2008. Translational and Clinical Pharmacology

显示全部楼层 · 发表于 2025-3-24 09:36:54

显示全部楼层 · 发表于 2025-3-24 12:13:02

Submitted on: 27 August 2015. Revised on: 03 October 2015. Accepted on: 12 October 2015. Translational and Clinical Pharmacology

显示全部楼层 · 发表于 2025-3-24 18:42:05

Submitted on: 18 December 1998. Revised on: 30 January 1999. Accepted on: 11 February 1999. Translational and Clinical Pharmacology

显示全部楼层 · 发表于 2025-3-24 21:06:42

显示全部楼层 · 发表于 2025-3-25 00:34:42

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-8 08:10
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved